Clinical Trial Update: Study of the Safety of Use of Intravitreal SOK583A1 Provided in a Vial Kit [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the safety of intravitreal SOK583A1 in a vial kit for neovascular age-related macular degeneration has completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• SOK583A1

Snippet

Sponsor: Sandoz | Conditions: Neovascular Age-related Macular Degeneration (nAMD) | Phase 3 | Status: COMPLETED | Results posted: 2023-05-10